Total Payments
$8,483
2024 Payments
$3,349
Companies
38
Transactions
136
Medicare Patients
877
Medicare Billing
$123,207
Payment Breakdown by Category
Food & Beverage$8,483 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,483 | 136 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $721.87 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $706.64 | 6 | $0 (2024) |
| Novo Nordisk Inc | $670.05 | 12 | $0 (2024) |
| Corcept Therapeutics | $563.54 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $471.62 | 5 | $0 (2024) |
| ABBVIE INC. | $457.11 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $455.16 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $424.39 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $375.06 | 3 | $0 (2024) |
| ITI, Inc. | $342.33 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,349 | 83 | Corcept Therapeutics ($333.22) |
| 2023 | $1,854 | 18 | Novo Nordisk Inc ($253.20) |
| 2022 | $2,025 | 21 | ITI, Inc. ($342.33) |
| 2021 | $1,255 | 14 | Teva Pharmaceuticals USA, Inc. ($234.23) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.96 | General |
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $5.26 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $11.11 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $100.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $112.45 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $122.74 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.23 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 161 | 675 | $91,344 | $32,535 |
| 2022 | 4 | 263 | 897 | $123,624 | $40,911 |
| 2021 | 4 | 213 | 775 | $104,510 | $34,064 |
| 2020 | 6 | 240 | 372 | $53,653 | $15,697 |
Total Patients
877
Total Services
2,719
Medicare Billing
$123,207
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 71 | 501 | $65,130 | $24,323 | 37.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 25 | 109 | $14,170 | $5,331 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 40 | $7,794 | $1,786 | 22.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 25 | 25 | $4,250 | $1,095 | 25.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 77 | 618 | $80,340 | $27,582 | 34.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 37 | 129 | $16,770 | $5,872 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 86 | $16,864 | $4,643 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 40 | $5,330 | $1,475 | 27.7% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 24 | 24 | $4,320 | $1,338 | 31.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 92 | 629 | $81,770 | $27,024 | 33.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 24 | 46 | $5,980 | $2,006 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 35 | $7,064 | $1,956 | 27.7% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2021 | 22 | 22 | $3,960 | $1,347 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 29 | $3,858 | $1,126 | 29.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 14 | $1,878 | $604.67 | 32.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 65 | 148 | $19,240 | $7,000 | 36.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 69 | 117 | $19,890 | $4,749 | 23.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 27 | 27 | $4,108 | $1,300 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 26 | $4,180 | $844.54 | 20.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 25 | $2,570 | $678.55 | 26.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 17 | $1,625 | $573.26 | 35.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 11 | 12 | $2,040 | $551.38 | 27.0% |
About Rose Julian, ANP-C
Rose Julian, ANP-C is a Nurse Practitioner healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2009. The National Provider Identifier (NPI) number assigned to this provider is 1235364530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rose Julian, ANP-C has received a total of $8,483 in payments from pharmaceutical and medical device companies, with $3,349 received in 2024. These payments were reported across 136 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,483).
As a Medicare-enrolled provider, Julian has provided services to 877 Medicare beneficiaries, totaling 2,719 services with total Medicare billing of $123,207. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Adult Health, Adult Health
- Location Fort Worth, TX
- Active Since 05/16/2009
- Last Updated 12/19/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1235364530
Products in Payments
- JARDIANCE (Drug) $615.84
- Korlym (Drug) $563.54
- VRAYLAR (Drug) $344.20
- CAPLYTA (Drug) $342.33
- XIFAXAN (Drug) $316.51
- REXULTI (Drug) $303.61
- MOUNJARO (Drug) $291.10
- TZIELD (Biological) $257.87
- JORNAY PM (Drug) $256.23
- AREXVY (Drug) $241.35
- AUSTEDO (Drug) $234.23
- Austedo XR (Drug) $228.68
- Auvelity (Drug) $178.36
- INVEGA SUSTENNA (Drug) $163.51
- BREZTRI (Drug) $139.01
- INGREZZA (Drug) $129.96
- DEXCOM G7 GSS (161) (Medical Supply) $125.56
- Veozah (Drug) $125.09
- Kerendia (Drug) $124.99
- NEXLIZET (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fort Worth
Mrs. Jennifer West, Np, NP
Nurse Practitioner — Payments: $63,534
Nurse Practitioner $63,534
Deborah Stapel, N.p, N.P
Nurse Practitioner — Payments: $31,024
Nurse Practitioner $31,024
Jessica Roth
Nurse Practitioner — Payments: $11,855
Nurse Practitioner $11,855
Kathryn Moreland, Np, NP
Nurse Practitioner — Payments: $11,350
Nurse Practitioner $11,350
Cynthia Roger, Rn Msn, RN MSN
Nurse Practitioner — Payments: $11,112
Nurse Practitioner $11,112
Carrie Platt, Arnp, ARNP
Nurse Practitioner — Payments: $8,246
Nurse Practitioner $8,246